Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
Jubilant Pharmova Ltd reported Revenues for Q2FY25 of ₹1,752.00 Crores up from ₹1,680.00 Crore year on year, a rise of 4.29%.
Total Expenses for Q2FY25 of ₹1,615.00 Crores up from ₹1,601.00 Crores year on year, a rise of 0.87%.
Consolidated Net Profit of ₹102.00 Crores up 64.52% from ₹62.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹6.45, up 64.54% from ₹3.92 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.